Search research articles
Contact Us
Filters
Showing results (121-130 of 127) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 127 results.
British Journal of Haematology
|
May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres
G Gahrton, H Svensson, M Cavo, et al.
Leukemia
|
June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
F J Giles, E Abruzzese, G Rosti, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
British Journal of Haematology
|
May 15, 2024
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry
B Ferment, J Lambert, D Caillot, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 127) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 127 results.
British Journal of Haematology
|
May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres
G Gahrton, H Svensson, M Cavo, et al.
Leukemia
|
June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
F J Giles, E Abruzzese, G Rosti, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
British Journal of Haematology
|
May 15, 2024
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry
B Ferment, J Lambert, D Caillot, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Page
of 13